Biosynth

Biosynth is a global life science company specializing in reagents, custom synthesis, and manufacturing services for pharmaceutical, diagnostic, and research applications. Headquartered in Staad, Switzerland, the company manufactures fine chemicals, peptides, and critical biologics at production facilities across Switzerland, the UK, Slovakia, and China, serving customers across four continents including major pharma and diagnostics companies. Biosynth supplies raw materials and custom-synthesized compounds at both small and large scales, including to GMP quality standards, and has expanded through acquisitions including the addition of celares GmbH as a PEGylation services specialist in 2023.